Brief: Codiak Presents New Preclinical Data Supporting Development Of A Broadly Protective Pan Beta-Coronavirus Vaccine
April 20 (Reuters) - Codiak BioSciences, Inc. CDAK.O :
* CODIAK PRESENTS NEW PRECLINICAL DATA SUPPORTING
DEVELOPMENT OF A
BROADLY PROTECTIVE PAN BETA-CORONAVIRUS VACCINE
Source text for Eikon: ID:nGNX9bW6gr
Further company coverage: CDAK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codiak BioSciences,.
See all newsBrief: Codiak Biosciences Notice From Listing Qualifications Department Of Nasdaq Trading Of Co's Common Stock To Be Suspended At Opening Of Business On April 5
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy